GSK’s Arexvy RSV Vaccine Approved for Broader Adult Use by European Regulators
**GSK’s Arexvy RSV Vaccine Approved for Broader Adult Use by European Regulators** Key Takeaways: GSK’s RSV vaccine, Arexvy, receives positive CHMP opinion for adults 18 and older The updated recommendation expands access beyond adults aged 60+ Regulatory decision from the European Commission expected in coming months London — RSV is trending after the European Medicines … Read more